SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
13/07/26	€0.0830	-0.60%	29,113
10/07/26	€0.0835	+1.83%	316,266
09/07/26	€0.0820	-1.80%	1,054,779
08/07/26	€0.0835	-1.88%	112,384
07/07/26	€0.0851	+1.92%	406,006

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Market Closed - Euronext Paris Other stock markets 16:55:00 13/07/2026 BST			5-day change	1st Jan Change
0.0830 ^EUR	-0.60%		-0.60%	-17.82%

07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026

Market Cap	7.84M 8.94M 7.26M 6.68M 12.64M 856M 12.88M 86.54M 33.94M 420M 33.56M 32.83M 1.45B	P/E 2024	-3.63x	P/E 2025	-3.37x
Enterprise Value	7.57M 8.64M 7.02M 6.45M 12.21M 827M 12.45M 83.61M 32.79M 406M 32.43M 31.72M 1.4B	EV / Sales 2024	2.94x	EV / Sales 2025	2.33x
Free-Float	97.68%	Yield 2024 *	-	Yield 2025	-

07-08	Spineguard SA Reports Unaudited Consolidated Revenue Results for the Second Quarter and First Half of 2026	CI
07-07	Zonebourse earnings calendar for company results: July 8, 2026
05-27	SpineGuard Secures Three Patent Applications in US	MT
05-26	SpineGuard granted three new patents in the United States
05-26	Spineguard Obtains Three New Patents for Full Protection in the United States of Its Innovative Solutions Integrating Dsg Technology	CI
04-28	SpineGuard Officially Launches Newly Cleared Curved and XS PediGuard Models, in Nanjing	CI
04-14	SpineGuard Transfers US Unit's Assets, Executes Distribution Deal with Omnia Medical	MT
04-13	SpineGuard and Omnia Medical Complete Us Asset Transfer and Enter Exclusive Distribution Agreement for Pediguard Devices	CI
04-13	Omnia Medical, LLC completed the acquisition of Spineguard, Inc. from SpineGuard SA.	CI
04-08	SpineGuard SA Auditor Raises 'Going Concern' Doubt	CI
04-08	SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-08	Danone, Eramet, Engie, LDC, Rémy Cointreau... stocks to watch today in Paris
04-07	Engie, LDC, Technip Energies... stocks to watch tomorrow in Paris

07-08	SpineGuard Announces its H1 2026 Revenue	BU
05-26	SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology	BU
04-28	SpineGuard : Official launch of three New PediGuard® Models during the Annual Scoliosis Meeting in China	PU
04-28	SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China	BU
04-14	14 April 2026 – 10H00 CET: SpineGuard note by BioStrategic Research (in english)	PU

SpineGuard Share Price

Stocks

ALSGD

FR0011464452

Medical Equipment, Supplies & Distribution

Valuation: SpineGuard

Chart: SpineGuard

Latest news : SpineGuard

Analysts' recommendations: SpineGuard

Press Releases: SpineGuard

News in other languages: SpineGuard

Quotes and Performance

Course Extremes

Managers and Directors: SpineGuard

Medical Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

07-08	SpineGuard en mesure de financer son activité jusqu'au deuxième trimestre 2027
07-08	SpineGuard annonce son chiffre d’affaires du premier semestre 2026
07-07	Agenda Zonebourse des résultats de sociétés : le 8 juillet 2026
06-10	Compte rendu de l’Assemblée Générale Mixte de SpineGuard du 10 juin 2026
06-05	Agenda des dividendes et des AG : des coupons chez Saint-Gobain et Orange

1 day	-0.60%
1 week	-0.60%
Current month	-1.66%
1 month	-4.60%
3 months	-22.86%
6 months	-25.23%
Current year	-17.82%

1 week	0.08	0.09
1 month	0.08	0.1
Current year	0.08	0.14
1 year	0.08	0.3
3 years	0.08	0.66
5 years	0.08	1.77
10 years	0.08	5.49

Manager	Title	Age	Since
Pierre Jérôme CEO	Chief Executive Officer	-	14/02/2020
Anne-Charlotte Millard DFI	Director of Finance/CFO	-	31/12/2008
Thibault Chandanson CTO	Chief Tech/Sci/R&D Officer	-	31/08/2019

Director	Title	Age	Since
Stéphane Bette BRD	Director/Board Member	-	15/01/2009
Maurice Bourlion BRD	Director/Board Member	-	01/07/2009
Pierre Jérôme CHM	Chairman	-	28/02/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SPINEGUARD	-0.60%	-0.60%	-6.74%	-83.13%	8.96M
PENUMBRA, INC.	+0.02%	-0.01%	+32.96%	-0.27%	12.51B
ASAHI INTECC CO., LTD.	+0.14%	-7.40%	+56.04%	+32.72%	5.87B
GETINGE AB	+1.20%	+2.09%	+11.60%	+14.12%	5.87B
MINIMED GROUP, INC.	+3.50%	+2.78%	-	-	4.29B
APT MEDICAL INC.	+1.14%	+6.45%	-29.76%	+17.14%	4.26B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+1.11%	-1.09%	-24.13%	-27.38%	3.83B
IMPLANTICA AG	-3.33%	-1.09%	+2.57%	+260.45%	1.94B
NOVOCURE LIMITED	-1.32%	-7.33%	-7.86%	-59.94%	1.89B
NAKANISHI INC.	-0.66%	+0.17%	+54.20%	-2.59%	1.56B
Average	+0.14%	+0.40%	+9.88%	+16.79%	4.2B
Weighted average by Cap.	+0.56%	-0.04%	+17.61%	+16.61%

	2024	2025
Net sales	4.65M 5.3M 4.3M 3.96M 7.49M 507M 7.64M 51.31M 20.12M 249M 19.9M 19.46M 860M	3.76M 4.28M 3.48M 3.2M 6.06M 410M 6.17M 41.48M 16.27M 201M 16.09M 15.73M 695M
Net income	-3.08M -3.51M -2.85M -2.63M -4.97M -336M -5.06M -34.02M -13.34M -165M -13.19M -12.91M -570M	-2.07M -2.36M -1.91M -1.76M -3.33M -226M -3.4M -22.82M -8.95M -111M -8.85M -8.66M -383M
Net Debt	1.82M 2.07M 1.68M 1.55M 2.93M 198M 2.99M 20.08M 7.87M 97.46M 7.79M 7.62M 337M	-265K -303K -246K -226K -428K -28.96M -436K -2.93M -1.15M -14.22M -1.14M -1.11M -49.11M